Dr. Hongbo Guo 郭洪波
Chief Physician, Associate Professor
Thoracic Surgery, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Thoracoscopic minimally invasive surgery for lung nodules (including GGO), sublobar resection, and thymoma. Multidisciplinary team treatment for advanced esophageal and lung cancer.
Dr. Guo earned a medical degree from Qingdao Medical College in 1993 and a PhD in Surgery from Shandong University in 2001. After postdoctoral research at Tianjin Medical University, Dr. Guo trained in thoracic surgery at Stanford University (2009–2010). With over 20 years of experience, Dr. Guo received the Best Strength Award at the 2017 International Thoracoscopic Surgery Competition.
Professional roles
- Member, Thoracic Oncology Branch, Chinese Medical Doctor Association
- Youth Committee Member, Lung Cancer Professional Committee, China Anti-Cancer Association
- Vice Chair, Youth Committee, Shandong Thoracic Surgery Lung Cancer Alliance
- Standing Committee Member, Thoracic Oncology Branch, Shandong Anti-Cancer Association
Name order: in Chinese the family name comes first (Guo Hongbo). Papers usually list the name as Hongbo Guo or Guo H.
Selected publications
43 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Ann Surg Oncol, 2026 (senior author): ASO Author Reflections: Unmasking the Silent Threat: Myocardial Injury After Lung Cancer Surgery and Its Link to Major Adverse Cardiovascular Events. PubMed 41851515
- Ann Surg Oncol, 2026 (senior author): Myocardial Injury After Lung Cancer Surgery: Incidence, Characteristics, Risk Factors, and Prognosis: A Retrospective Cohort Study. PubMed 41784722
- Front Oncol, 2025 (senior author): Deep learning radiomics model of epicardial adipose tissue for predicting postoperative atrial fibrillation after lung lobectomy in lung cancer patients. PubMed 41158854
- Sci Rep, 2025 (senior author): Clinical outcomes of conversion surgery following neoadjuvant chemoimmunotherapy in potentially resectable stage IIIA/IIIB non-small cell lung. PubMed 40419636
- Cancer Immunol Immunother, 2025 (senior author): Comparison of neoadjuvant chemoimmunotherapy with planned surgery and concurrent chemoradiation followed by immunotherapy for potentially resectable stage III non-small-cell lung cancer: a retrospective study. PubMed 39998638
- Front Immunol, 2024 (senior author): Case report: The outcomes of neoadjuvant immunotherapy combined with chemotherapy in pulmonary sarcomatoid carcinoma: case series and literature review. PubMed 39660137
- J Thorac Dis, 2024 (senior author): Pathological responses of primary tumor and lymph nodes in non-small cell lung cancer after neoadjuvant chemoimmunotherapy: a retrospective real-world study. PubMed 39552859
- Clin Respir J, 2024 (senior author): Role of Surgery in Potentially Resectable Small-Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: A Population Study of the US SEER Database. PubMed 39428911
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion